News | December 17, 2024
Merck to acquire HUB Organoids to advance cell culture portfolio
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
A 40 minute daily Yoga routine, incorporating select asanas and pranayama, along with standard lifestyle interventions, can reduce the risk of developing diabetes by approximately 40%
The CDMO business will be structured into three new business platforms designed to create a unified organization: Integrated Biologics, Advanced Synthesis, and Specialized Modalities
MedGenome reaffirms its commitment to broaden access to quality and affordable genetic solutions for all
We now rank 3rd in pharmaceutical production by volume and 14th by value
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
MoU signed to drive digital transformation through strategic projects across all three business sectors of Merck
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Increases efficiency by 70% compared to stainless steel or glass manufacturing methods
Transform healthcare by integrating expertise from AI, clinical sciences, and basic sciences to harness India’s extensive data sets for improving the access to healthcare
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
